Evidence map›Paper›PMID 35936750›Full record

ArticleFrontiers in oncology2022

Silvia A Teixeira, Regislaine V Burim, Mariano S Viapiano, Lucas T Bidinotto, Suely K Nagashi Marie, Suzana M Fleury Malheiros, Sueli M Oba-Shinjo, Augusto F Andrade, Carlos G Carlotti

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 87% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Silvia A TeixeiraDepartment of Surgery and Anatomy, Ribeirão Preto Medical School, University of São Paulo (USP), São Paulo, Brazil.
Regislaine V BurimDepartment of Surgery and Anatomy, Ribeirão Preto Medical School, University of São Paulo (USP), São Paulo, Brazil.
Mariano S ViapianoDepartment of Neurosurgery, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States.
Lucas T BidinottoDepartment of Surgery and Anatomy, Ribeirão Preto Medical School, University of São Paulo (USP), São Paulo, Brazil.
Suely K Nagashi MarieDepartment of Neurology, Medical School, University of São Paulo (USP), São Paulo, Brazil.
Suzana M Fleury MalheirosDepartment of Neurology, Faculty of Medicine, Federal University of São Paulo (UNIFESP), São Paulo, Brazil.
Sueli M Oba-ShinjoDepartment of Internal Medicine, Faculty of Medicine, University of São Paulo (USP), São Paulo, Brazil.
Augusto F AndradeDepartment of Human Genetics, McGill University, Montreal, QC, Canada.
Carlos G CarlottiDepartment of Surgery and Anatomy, Ribeirão Preto Medical School, University of São Paulo (USP), São Paulo, Brazil.
Universidade de São Paulo · BRHarvard University · USMcGill University · CAUniversidade Estadual Paulista (Unesp) · BRUniversidade Federal de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Integrins are heterodimeric transmembrane glycoproteins resulting from the non-covalent association of an α and β chain. The major integrin receptor for collagen/laminin, α2β1 is expressed on a wide variety of cell types and plays an essential role in the adhesion of normal and tumor cells to the extracellular matrix. Integrin-triggered signaling pathways promote the invasion and survival of glioma cells by modifying the brain microenvironment. In this study, we investigated the association of a specific genetic polymorphism of integrin

Indexed as

brain microenvironmentextracellular matrixinvasionITGA2low grade gliomasingle nucleotide polymorphismtumor progression

Identifiers

PMID35936750
PMCPMC9353741
OpenAlexW4286698785

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.